5th Annual Ion Channels in Drug Discovery & Development

Venue: Philadelphia Marriott

Location: Philadelphia, Pennsylvania, United States

Event Date/Time: Jul 19, 2005 End Date/Time: Jul 20, 2005
Report as Spam

Description

This year’s meeting is focused on new targets, structure function studies and the latest applications and technologies for ion channel drug discovery. Development and safety evaluation of ion channel drugs will be covered in great detail, presented by the distinguished faculty of over twenty industry leading scientists and academicians from the ion channels and biophysics community, including:

Featuring

Structure-Function Mapping of the KChiP/Kv4 Interface

Kenneth J. Rhodes, Ph.D.,
Research Fellow and Co-Team Leader, Neurological Disorders
Johnson & Johnson Pharmaceutical Research and Development

Inhibition of Native and Recombinant Nicotinic Acetylcholine Receptors by ApoE-derived Peptides

Jerry Yakel, Ph.D.,
Senior Investigator
National Institutes of Health

Sodium-dependent Potassium Channels

Valentin Gribkoff, Ph.D.,
Vice President, Biology
Scion Pharmaceuticals

Presenting:

Abbott Laboratories
AstraZeneca
Cellectricon
Chantest
Eli Lilly
Flyion GMBH
GlaxoSmithKline
Johnson & Johnson PRD
Lectus Therapeutics
Memory Pharmaceuticals
Merck
Molecular Devices Corporation
National Institutes of Health
National Cancer Institute
Neurion Pharmaceuticals
Novartis Institute for Biomedical Research
Novartis Respiratory Research Centre
Quintiles
Schering-Plough
Scion Pharmaceuticals
Sophion
Synta Pharmaceuticals
Vertex Pharmaceuticals
Wyeth

Venue

1201 Market Street
Philadelphia
Pennsylvania
United States
MORE INFO ON THIS VENUE